Tvardi Therapeutics, Inc. (TVRD)
Healthcare
Biotechnology
2.10 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Tvardi Therapeutics, Inc. (TVRD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -5.5 | -60 | -18 | -21 | -61 | -23 | |
| 1.0 | 1.6 | 0.1 | 0.1 | 0.2 | 0.1 | |
| – | – | 0.2 | 0.3 | 0.3 | 1.4 | |
| -7.4 | 5.3 | 2.7 | -4.0 | -15 | 0.5 | |
| 0.3 | 0.0 | 0.1 | 2.4 | 1.0 | 0.0 | |
| -20 | -4.8 | -22 | 22 | 49 | -10 | |
| – | – | – | – | 28 | 0.0 | |
| 39 | 47 | 0.0 | 0.0 | -3.6 | 23 | |
| 13 | -18 | -40 | 1.4 | -14 | -11 | |
| -5.8 | -60 | -18 | -21 | -62 | -23 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.